| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 238.72B | 245.55B | 237.16B | 227.58B | 213.52B | 204.35B |
| Gross Profit | 88.42B | 84.11B | 87.80B | 84.11B | 77.59B | 73.04B |
| EBITDA | 17.71B | 23.97B | 23.70B | 22.72B | 18.72B | 17.31B |
| Net Income | 11.41B | 10.68B | 11.47B | 10.68B | 7.57B | 6.66B |
Balance Sheet | ||||||
| Total Assets | 211.77B | 217.27B | 191.45B | 186.94B | 172.54B | 165.80B |
| Cash, Cash Equivalents and Short-Term Investments | 74.01B | 79.53B | 59.84B | 54.85B | 39.30B | 31.59B |
| Total Debt | 3.77B | 264.00M | 277.00M | 289.00M | 302.00M | 314.00M |
| Total Liabilities | 56.16B | 56.31B | 36.90B | 40.79B | 35.13B | 34.08B |
| Stockholders Equity | 151.52B | 156.41B | 150.51B | 142.40B | 134.01B | 128.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.00B | 8.87B | 18.27B | 9.91B | -1.98B |
| Operating Cash Flow | 0.00 | 31.62B | 14.98B | 21.18B | 14.74B | 4.08B |
| Investing Cash Flow | 0.00 | -6.49B | -6.20B | -3.13B | -5.07B | -6.37B |
| Financing Cash Flow | 0.00 | -5.44B | -3.79B | -2.51B | -1.96B | -6.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥209.44B | 7.25 | ― | 2.18% | 6.30% | 27.88% | |
73 Outperform | ¥213.16B | 18.46 | 7.56% | 2.70% | 2.28% | 3.61% | |
63 Neutral | ¥229.20B | 17.32 | ― | 3.01% | 18.89% | -34.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥191.78B | -33.75 | ― | 1.77% | 30.67% | ― | |
57 Neutral | ¥194.35B | 8.93 | ― | 1.44% | 1.48% | -33.32% | |
53 Neutral | ¥32.64B | 136.89 | ― | 3.11% | 1.46% | -436.55% |